Drug Design Methodologies develops novel software to chemically optimize and accurately measure drug-target binding.

By identifying and focusing resources upon the most promising candidates and eliminating problematic compounds that could exhibit off-target effects, we accelerate and de-risk drug development pipelines in both pharmaceutical and biotechnology industries while lowering costs.

For more information, visit Drug Design Methodologies or follow their updates on: